Lettl, C.* ; Schindele, F.* ; Mehdipour, A.R.* ; Steiner, T.* ; Ring, D.* ; Brack-Werner, R. ; Stecher, B.* ; Eisenreich, W.* ; Bilitewski, U.* ; Hummer, G.* ; Witschel, M.* ; Fischer, W.* ; Haas, R.*
Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors.
Cell Chem. Bio. 30, 499-512.e5 (2023)
Respiratory complex I is a multicomponent enzyme conserved between eukaryotic cells and many bacteria, which couples oxidation of electron donors and quinone reduction with proton pumping. Here, we report that protein transport via the Cag type IV secretion system, a major virulence factor of the Gram-negative bacterial pathogen Helicobacter pylori, is efficiently impeded by respiratory inhibition. Mitochondrial complex I inhibitors, including well-established insecticidal compounds, selectively kill H. pylori, while other Gram-negative or Gram-positive bacteria, such as the close relative Campylobacter jejuni or representative gut microbiota species, are not affected. Using a combination of different phenotypic assays, selection of resistance-inducing mutations, and molecular modeling approaches, we demonstrate that the unique composition of the H. pylori complex I quinone-binding pocket is the basis for this hypersensitivity. Comprehensive targeted mutagenesis and compound optimization studies highlight the potential to develop complex I inhibitors as narrow-spectrum antimicrobial agents against this pathogen.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cag Type Iv Secretion System ; Helicobacter Pylori ; Antibiotic Resistance ; Narrow-spectrum Antibiotics ; Pathogen Blockers ; Pathogenicity Factors ; Quinone-binding Cavity ; Respiratory Complex I ; Small-molecule Inhibitors; Nadh-ubiquinone Oxidoreductase; Antibiotic-resistance; Campylobacter-jejuni; Escherichia-coli; Gene-transfer; Secretion; Evolution; Cancer; Caga; Strategies
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
2451-9448
e-ISSN
2451-9456
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 30,
Issue: 5,
Pages: 499-512.e5
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge, Massachusetts
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-001
Grants
German Center for Infection Research (DZIF)
Copyright
Erfassungsdatum
2023-10-06